Dr. Mammen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Ave
Baltimore, MD 21224Phone+1 410-550-5624
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2004 - 2005- Johns Hopkins UniversityResidency, Neurology, 2001 - 2004
- Johns Hopkins UniversityInternship, Internal Medicine, 2000 - 2001
- Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
MD State Medical License 2004 - 2025
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 1 citationsClinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza
Arthritis & Rheumatology. 2025-04-01 - The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project.Giovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, Sara Faghihi-Kashani, Akira Yoshida
Annals of the Rheumatic Diseases. 2025-03-18 - Distinct Cytokine and Cytokine Receptor Expression Patterns Characterize Different Forms of Myositis.Raphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, Katherine Pak, Corinna Preusse
Medrxiv. 2025-02-21
Press Mentions
Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing MyopathyJune 4th, 2019- Update on MyositisOctober 25th, 2018
Atorvastatin-Induced Necrotizing Autoimmune Myositis: An Emerging Dominant Entity in Patients with Autoimmune Myositis Presenting with a Pure Polymyositis PhenotypeJanuary 23rd, 2017- Join now to see all
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/andrew-mammen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
